These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 28667074)
21. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells. Cao C; Wu H; Vasilatos SN; Chandran U; Qin Y; Wan Y; Oesterreich S; Davidson NE; Huang Y Int J Cancer; 2018 Sep; 143(6):1388-1401. PubMed ID: 29633255 [TBL] [Abstract][Full Text] [Related]
22. The SNAG Domain of Insm1 Regulates Pancreatic Endocrine Cell Differentiation and Represses β- to δ-Cell Transdifferentiation. Liang X; Duan H; Mao Y; Koestner U; Wei Y; Deng F; Zhuang J; Li H; Wang C; Hernandez-Miranda LR; Tao W; Jia S Diabetes; 2021 May; 70(5):1084-1097. PubMed ID: 33547047 [TBL] [Abstract][Full Text] [Related]
23. LPE-1, an orally active pyrimidine derivative, inhibits growth and mobility of human esophageal cancers by targeting LSD1. Wang B; Zhao B; Pang LP; Zhao YD; Guo Q; Wang JW; Zheng YC; Zhang XH; Liu Y; Liu GY; Guo WG; Wang C; Li ZH; Mao XJ; Yu B; Ma LY; Liu HM Pharmacol Res; 2017 Aug; 122():66-77. PubMed ID: 28571892 [TBL] [Abstract][Full Text] [Related]
24. Cisplatin and photodynamic therapy exert synergistic inhibitory effects on small-cell lung cancer cell viability and xenograft tumor growth. Cheng YS; Peng YB; Yao M; Teng JP; Ni D; Zhu ZJ; Zhuang BF; Yang ZY Biochem Biophys Res Commun; 2017 Jun; 487(3):567-572. PubMed ID: 28431928 [TBL] [Abstract][Full Text] [Related]
25. GFI1B and LSD1 repress myeloid traits during megakaryocyte differentiation. Venhuizen J; van Bergen MGJM; Bergevoet SM; Gilissen D; Spruijt CG; Wingens L; van den Akker E; Vermeulen M; Jansen JH; Martens JHA; van der Reijden BA Commun Biol; 2024 Mar; 7(1):374. PubMed ID: 38548886 [TBL] [Abstract][Full Text] [Related]
27. Interference of lysine-specific demethylase 1 inhibits cellular invasion and proliferation in vivo in gastric cancer MKN-28 cells. Li Y; Tian X; Sui CG; Jiang YH; Liu YP; Meng FD Biomed Pharmacother; 2016 Aug; 82():498-508. PubMed ID: 27470390 [TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and evaluation of γ-turn mimetics as LSD1-selective inhibitors. Ota Y; Miyamura S; Araki M; Itoh Y; Yasuda S; Masuda M; Taniguchi T; Sowa Y; Sakai T; Itami K; Yamaguchi J; Suzuki T Bioorg Med Chem; 2018 Feb; 26(3):775-785. PubMed ID: 29331452 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value and non-neuroendocrine role of INSM1 in small cell lung cancer. Xu X; Wang G; Duan Y; Huo Z Pathol Res Pract; 2022 Jan; 229():153693. PubMed ID: 34826740 [TBL] [Abstract][Full Text] [Related]
30. Taking SCLC on a Bad LSD(1) Trip One NOTCH Further. Kim J; Sage J Trends Mol Med; 2019 Apr; 25(4):261-264. PubMed ID: 30852141 [TBL] [Abstract][Full Text] [Related]
31. Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models. Yang CY; Lin CK; Tsao CH; Hsieh CC; Lin GJ; Ma KH; Shieh YS; Sytwu HK; Chen YW Oncotarget; 2017 May; 8(20):33756-33769. PubMed ID: 28422711 [TBL] [Abstract][Full Text] [Related]
32. Nelfinavir Inhibits the Growth of Small-cell Lung Cancer Cells and Patient-derived Xenograft Tumors. Kawabata S; Connis N; Gills JJ; Hann CL; Dennis PA Anticancer Res; 2021 Jan; 41(1):91-99. PubMed ID: 33419802 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing. Hiatt JB; Sandborg H; Garrison SM; Arnold HU; Liao SY; Norton JP; Friesen TJ; Wu F; Sutherland KD; Rienhoff HY; Martins R; Houghton AM; Srivastava S; MacPherson D Clin Cancer Res; 2022 Oct; 28(20):4551-4564. PubMed ID: 35920742 [TBL] [Abstract][Full Text] [Related]
34. TSPAN12 promotes chemoresistance and proliferation of SCLC under the regulation of miR-495. Ye M; Wei T; Wang Q; Sun Y; Tang R; Guo L; Zhu W Biochem Biophys Res Commun; 2017 Apr; 486(2):349-356. PubMed ID: 28302484 [TBL] [Abstract][Full Text] [Related]
35. ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway. Li Y; Tao L; Zuo Z; Zhou Y; Qian X; Lin Y; Jie H; Liu C; Li Z; Zhang H; Zhang H; Cen X; Yang S; Zhao Y Cancer Lett; 2019 Jul; 454():179-190. PubMed ID: 30978443 [TBL] [Abstract][Full Text] [Related]
36. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway. Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778 [TBL] [Abstract][Full Text] [Related]
37. Combination of arsenic trioxide and chemotherapy in small cell lung cancer. Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618 [TBL] [Abstract][Full Text] [Related]
38. Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo. Helfrich BA; Kim J; Gao D; Chan DC; Zhang Z; Tan AC; Bunn PA Mol Cancer Ther; 2016 Oct; 15(10):2314-2322. PubMed ID: 27496133 [TBL] [Abstract][Full Text] [Related]
39. Gambogenic acid inhibits the proliferation of small‑cell lung cancer cells by arresting the cell cycle and inducing apoptosis. Huang T; Zhang H; Wang X; Xu L; Jia J; Zhu X Oncol Rep; 2019 Mar; 41(3):1700-1706. PubMed ID: 30592285 [TBL] [Abstract][Full Text] [Related]
40. Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion. Ferrari-Amorotti G; Fragliasso V; Esteki R; Prudente Z; Soliera AR; Cattelani S; Manzotti G; Grisendi G; Dominici M; Pieraccioli M; Raschellà G; Chiodoni C; Colombo MP; Calabretta B Cancer Res; 2013 Jan; 73(1):235-45. PubMed ID: 23054398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]